Tammy Baldwin
Press Release

Senators Raise Concerns About Mylan’s EpiPen Price Hike and Expanded Patient Assistance Program

Patient assistance program allows company to increase drug prices while passing costs onto insurance companies and consumers

By - Aug 30th, 2016 10:09 am

WASHINGTON, D.C. – In a letter sent today to the CEO of pharmaceutical company Mylan, U.S. Senator Tammy Baldwin, along with 19 other senators, expressed serious concerns about the company’s recent significant price hikes for the life-saving EpiPen Auto-Injector. The senators raised questions about Mylan’s decision to expand its patient assistance program, which allows the company to sharply increase prices while passing the cost of these increases onto insurance companies and ultimately to consumers, and to introduce an authorized generic EpiPen at more than half the price of the branded EpiPen. The letter was signed by Senators Elizabeth Warren (D-MA), Tammy Baldwin (D-WI), Richard Blumenthal (D-CT), Barbara Boxer (D-CA), Sherrod Brown (D-OH), Joe Donnelly (D-IN), Richard J. Durbin (D-IL), Al Franken (D-MN), Heidi Heitkamp (D-ND), Mazie K. Hirono (D-HI), Amy Klobuchar (D-MN), Patrick Leahy (D-VT), Edward Markey (D-MA), Chris Murphy (D-CT), Jack Reed (D-RI), Bernie Sanders (I-VT), Brian Schatz (D-HI), Jon Tester (D-MT), Tom Udall (D-NM), and Sheldon Whitehouse (D-RI).

“The EpiPen…has become so exorbitantly expensive that access to this life saving combination product is in jeopardy for many Americans,” the senators wrote. “Mylan’s near monopoly on the epinephrine auto-injector market has allowed you to increase prices well beyond those that are justified by any increase in the costs of manufacturing the EpiPen.”

The letter notes that in response to public concern about the rising cost of the EpiPen, Mylan has expanded its current accessibility programs — including increasing the maximum value of its savings card from $100 to $300 — although the company would not reduce the EpiPen’s sticker price. The senators explain, “These changes will help some customers who are struggling to afford EpiPens. Your discount programs, however, represent a well-defined industry tactic to keep costs high through a complex shell game.”

“When patients receive short-term co-pay assistance for expensive drugs, they may be insulated from price hikes, but insurance companies, the government, and employers still bear the burden of these excessive prices. In turn, those costs are eventually passed on to consumers in the form of higher premiums, but the drug company is no longer in the spotlight. Because couponing can massively inflate costs, this practice has been outlawed by the government in Medicare and Medicaid. But couponing practices are perfectly legal for commercial insurance and Affordable Care Act exchange coverage.”

The senators requested that Mylan answer a series of questions to provide additional information about the impact that the EpiPen price hike and the associated changes in Mylan’s patient assistance program and other accessibility programs will have on consumers and on taxpayers.

Press Releases by Tammy Baldwin

Tammy Baldwin

U.S. Senator Tammy Baldwin Releases Statement on Nomination of Wealthy Insider with Deep Roots on Wall Street for Treasury Secretary

“Wisconsin families struggling to get ahead do not want foxes guarding the hen house.”

Tammy Baldwin

U.S. Senator Tammy Baldwin’s Bipartisan Digital Coast Act Unanimously Passes the Senate

Legislation aids Great Lakes communities by delivering next generation coastal data

Tammy Baldwin

U.S. Senator Tammy Baldwin Votes for Bipartisan Reform to Increase Access to High Quality Health Care in Rural Wisconsin

Rural communities in Wisconsin and across the country face many challenges in accessing high-quality health care.

Tammy Baldwin

U.S. Senators Tammy Baldwin, Jeanne Shaheen, Ed Markey, and Joe Donnelly Call for Investments to Fight Opioid Epidemic in 21st Century Cures Act

In the letter to Majority Leader McConnell and Minority Leader Reid, the Senators stressed the need to provide immediate funding to address the opioid epidemic.

Tammy Baldwin

U.S. Senator Tammy Baldwin and Mayor Tom Barrett Announces $6 Million for Workforce Development to Employ Milwaukee

The funds will be used to train 1,430 individuals, and coordinate regional planning to attract and retain businesses.

Tammy Baldwin
See More Releases

Leave a Reply

Your email address will not be published. Required fields are marked *